Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,121
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
for
Crohn's Disease
Location: North York, Vaughan, Oakville, London, Mentor OH,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06045754
Recruiting
SABR for Renal Tumors
for
Renal Tumor
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT03747133
Recruiting
Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)
for
Prostate Adenocarcinoma, Castration Sensitive Prostate Cancer
Location: Toronto, Hamilton, Montreal
Sponsor: Ontario Clinical Oncology Group (OCOG)
Sex: Male
Age: 18+
Code: NCT06654336
Phase 2, Recruiting
Feasibility of Multi-Energy Digital Radiography Detector for Lung Lesions Detection
for
Lung Tumor, Solitary Pulmonary Nodule
Location: Kitchener
Sponsor: KA Imaging Inc.
Sex: All
Age: 18+
Code: NCT03528733
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Toronto, North York, Cambridge, London, Akron OH,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase 3, Recruiting
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
for
Metastatic Colorectal Cancer
Location: Toronto, Sterling Heights MI, Ottawa, White Plains NY,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18+
Code: NCT07549412
Phase 3, Recruiting
Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease
for
Diabetes Mellitus, Type 2, Myocardial Infarction,
Location: Cambridge
Sponsor: Cambridge Cardiac Care Centre
Sex: All
Age: 18+
Code: NCT03103854
Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
for
Acne
Location: Toronto, Barrie, Allen Park MI, Dearborn Heights MI,
Sponsor: Sanofi Pasteur, a Sanofi Company
Sex: All
Age: 18 - 45
Code: NCT06316297
Phase 1, Phase 2, Recruiting
Web-based Interactive Health Communication Application (IHCA) for Successful Home Dialysis
for
Chronic Kidney Disease
Location: Hamilton
Sponsor: St. Joseph's Healthcare Hamilton
Sex: All
Age: 18+
Code: NCT01403454
Recruiting
Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder
for
Cannabis Use Disorder
Location: Toronto
Sponsor: Centre for Addiction and Mental Health
Sex: All
Age: 18 - 65
Code: NCT05859347
Recruiting
Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study
for
Thyroid Papillary Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07376837
Recruiting
A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC
for
Early Hepatocellular Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07628751
Recruiting
The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices
for
Intracranial Aneurysm, Brain Aneurysm,
Location: Hamilton, Montreal, Winnipeg, Edmonton
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Sex: All
Age: 18+
Code: NCT03936647
Recruiting
Capecitabine in ER+/HER2-negative Breast Cancer
for
ER-positive, HER2-negative Breast Cancer, Breast Cancer Stage I,
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07631052
Phase 2, Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
for
Non-squamous Non-small Cell Lung Cancer
Location: Hamilton, Buffalo NY, Kingston, Canton OH, York PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06627647
Phase 3, Recruiting
Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma
for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT07456605
Phase 1, Recruiting
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
for
Carcinoma, Non-Small-Cell Lung
Location: Toronto, Portland OR, Duarte CA, Irvine CA
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07586202
Phase 2, Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
for
IDH-mutant Grade 2 or 3 Astrocytoma
Location: Toronto, Winnipeg
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC